Amyloidose Virkningen af bortezomibs proteasomhæmning ved sygdomme forbundet med proteinakkumulation, f. eks. amyloidose, kendes ikke.
Amyloidosis The impact of proteasome inhibition by bortezomib on disorders associated with protein accumulation such as amyloidosis is unknown.